article thumbnail

The New Frontier in Drug Development: Understanding Biologics and Small Molecules

Cloudbyz

Drug Resistance: For diseases like cancer and infectious diseases, the development of resistance to small molecule drugs can be a significant challenge, requiring ongoing research into combination therapies or new mechanisms of action. Enhancing bioavailability is often a key focus in the development of small molecule drugs.

article thumbnail

XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

The Pharma Data

Each study is planned to be carried out over an approximately two-week period as an open label, randomized, crossover, two-period, two-sequence, single dose pilot study to assess the relative bioavailability of each product.

Drugs 52